zolbetuximab - CISMeF

Preferred Label : zolbetuximab;

MeSH note : in Phase IIa trial 1/14 for treatment of advanced gastroesophageal cancer (clincaltrials.gov: NCT00909025);

CISMeF synonym : claudiximab;

MeSH hyponym : IMAB-362;

UNII : TF5MPQ8WGY;

Details

Origin ID

C585662;

UMLS CUI

C2827697;

ATC code(s)
- zolbetuximab [ATC Code]
Currated CISMeF NLP mapping
- Zolbetuximab [NCIt concept]
- Zolbetuximab [SMS substance]
MeSH term(s) associated for indexing
- antibodies, monoclonal [MeSH Descriptor]
Record concept(s)
- IMAB362 [MeSH concept]
- claudiximab [MeSH concept]
- zolbetuximab [MeSH concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Immunologic Factor [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Zolbetuximab [NCIt concept]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients